GE Ventures, Mayo Clinic launch new personalized cell and gene therapy biz
by Michael Gibney
Two groups with deep pockets--GE Ventures and the Mayo Clinic--have joined forces to launch a new company devoted to personalized cell and gene therapy.
First 3-D DNA-nanogold imaging promises more intricate delivery structures
by Michael Gibney
The proteins that comprise DNA can be used to create complex structures for drug delivery and other applications because of their flexibility and ability to be…
Nanoparticle 'cluster-bomb' targets tumors to reduce chemo doses
by Michael Gibney
A team of scientists from the U.S. and China have devised a type of nanoparticle containing yet more nanoparticles, which together form a "cluster-bomb…
Augmenix touts study of its rectal spacer to cut radiotherapy effects
by Varun Saxena
Waltham, MA's Augmenix touted its FDA-cleared absorbable spacer for improving prostate cancer radiotherapy. By implanting the hydrogel spacer between the…
India's Rusan Pharma opens transdermal patch plant in Gujarat
by Varun Saxena
Mumbai, India's Rusan Pharma just inaugurated a $15 million facility dedicated to researching and manufacturing drug delivering transdermal patches in…
The FDA released a draft guidance requiring that generic version of abuse-deterrent opioids are at least as difficult to manipulate as the original med, as it…